|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
|
GTX30924
|
GeneTex International Corporation
|
Immuno In Situ Mount
|
|
IHC
|
|
|
HY-112929B-10mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-100mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-5mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-50mg
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0]
|
|
Cancer-programmed cell death
|
|
|
HY-112929B-1mL
|
MedChemexpress LLC
|
(1S,2S,3R)-DT-061 [CAS 1809427-20-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-100g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-25g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W007599-50g
|
MedChemexpress LLC
|
(S)-2,6-Bis((tert-butoxycarbonyl)amino)hexanoic acid [CAS 2483-46-7]
|
|
Cancer-programmed cell death
|
|
|
HY-106961A-1mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
|
HY-106961A-5mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
|
HY-19776-10mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-100mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-25mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-5mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-50mg
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4]
|
|
Cancer-programmed cell death
|
|
|
HY-19776-1mL
|
MedChemexpress LLC
|
3Alpha-Aminocholestane [CAS 2206-20-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138590-10mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-100mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-25mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-5mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-138590-50mg
|
MedChemexpress LLC
|
7-TFA-ap-7-Deaza-dA [CAS 178420-75-2]
|
|
Cancer-programmed cell death
|
|
|
HY-P7880-10ug
|
MedChemexpress LLC
|
Alkaline Phosphatase/ALPL, Human (HEK293, His)
|
|
|
|
|
HY-P7880-50ug
|
MedChemexpress LLC
|
Alkaline Phosphatase/ALPL, Human (HEK293, His)
|
|
|
|
